Urinary Tract Infections (UTI)

SGLT-2 Inhibitors Do Not Increase Risk for UTI in Type 2 Diabetes

Publish Date July 31, 2019

Study finds no increased risks for severe or nonsevere urinary tract infections with SGLT-2 inhibitor use compared with other second-line antidiabetic drugs in type 2 diabetes patients.

FDA Approves Recarbrio for Complicated UTI, Abdominal Infections

Publish Date July 17, 2019

The antibiotic Recarbrio is a combination of imipenem-cilastatin and relebactam.

Better UTI Monitoring Needed After Hospital Admission in Adults

Publish Date July 1, 2019

Many healthcare-associated, community-onset urinary tract infections develop after being discharged.

Infections Tied to Subsequent Risk for Acute Ischemic Stroke

Publish Date June 28, 2019

Correlation highest for UTI; smaller-magnitude associations seen for UTI with intracerebral hemorrhage

Investigational Oral Carbapenem Antibiotic Gets Fast-Tracked for cUTI, Acute Pyelonephritis

Publish Date April 5, 2019

Spero Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation for SPR994 (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)

Guidelines Developed for Polymyxin Antibiotic Use

Publish Date March 15, 2019

Polymyxin B recommended for routine use in invasive infections; colistin preferred for lower UTI

Fosfomycin Promising for Chronic Bacterial Prostatitis

Publish Date February 27, 2019

Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial resistance to which is becoming increasingly prevalent.

Study Supports Once-Daily Plazomicin Use for Complicated UTIs

Publish Date February 22, 2019

Plazomicin is superior to meropenem in treating complicated UTIs due Enterobacteriaceae not susceptible to aminoglycosides.

Machine Learning Methods Can Detect UTI in Dementia Patients

Publish Date January 29, 2019

Research team used novel algorithms to ID early symptoms of health declines in dementia patients.

SGLT2 Inhibitors and Urinary Tract Infections: What’s the Link?

Publish Date December 19, 2018

For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.